FMC Technologies (FTI) is an Incredible Growth Stock: 3 Reasons Why

15.04.26 18:45 Uhr

Werte in diesem Artikel
Aktien

11,45 EUR -0,30 EUR -2,55%

37,14 EUR 0,07 EUR 0,19%

SGD 0,00 SGD 0,00%

59,68 EUR -0,62 EUR -1,03%

Indizes

PKT PKT

2.082,0 PKT -25,6 PKT -1,21%

2.134,1 PKT -30,9 PKT -1,43%

24.338,6 PKT -325,0 PKT -1,32%

8.930,0 PKT -157,7 PKT -1,74%

1.912,5 PKT -34,1 PKT -1,75%

2.975,3 PKT 0,8 PKT 0,03%

2.143,9 PKT 0,6 PKT 0,03%

215,7 PKT -2,3 PKT -1,07%

634,9 PKT -5,1 PKT -0,79%

12.929,5 PKT -168,4 PKT -1,29%

24.397,0 PKT -5,0 PKT -0,02%

24.385,1 PKT -112,7 PKT -0,46%

9.433,8 PKT -121,2 PKT -1,27%

17.381,0 PKT -132,3 PKT -0,76%

1.854,4 PKT -8,4 PKT -0,45%

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock.That's because, these stocks usually carry above-average risk and volatility. In fact, betting on a stock for which the growth story is actually over or nearing its end could lead to significant loss.However, it's pretty easy to find cutting-edge growth stocks with the help of the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects.Our proprietary system currently recommends FMC Technologies (FTI) as one such stock. This company not only has a favorable Growth Score, but also carries a top Zacks Rank.Research shows that stocks carrying the best growth features consistently beat the market. And returns are even better for stocks that possess the combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy).Here are three of the most important factors that make the stock of this provider of equipment and services to energy companies a great growth pick right now.Earnings GrowthArguably nothing is more important than earnings growth, as surging profit levels is what most investors are after. And for growth investors, double-digit earnings growth is definitely preferable, and often an indication of strong prospects (and stock price gains) for the company under consideration.While the historical EPS growth rate for FMC Technologies is 95.4%, investors should actually focus on the projected growth. The company's EPS is expected to grow 19.2% this year, crushing the industry average, which calls for EPS growth of -3%.Cash Flow GrowthWhile cash is the lifeblood of any business, higher-than-average cash flow growth is more important and beneficial for growth-oriented companies than for mature companies. That's because, growth in cash flow enables these companies to expand their businesses without depending on expensive outside funds.Right now, year-over-year cash flow growth for FMC Technologies is 22.8%, which is higher than many of its peers. In fact, the rate compares to the industry average of -4.1%.While investors should actually consider the current cash flow growth, it's worth taking a look at the historical rate too for putting the current reading into proper perspective. The company's annualized cash flow growth rate has been 24% over the past 3-5 years versus the industry average of 14.1%.Promising Earnings Estimate RevisionsSuperiority of a stock in terms of the metrics outlined above can be further validated by looking at the trend in earnings estimate revisions. A positive trend is of course favorable here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements.There have been upward revisions in current-year earnings estimates for FMC Technologies. The Zacks Consensus Estimate for the current year has surged 0.3% over the past month.Bottom LineFMC Technologies has not only earned a Growth Score of B based on a number of factors, including the ones discussed above, but it also carries a Zacks Rank #1 because of the positive earnings estimate revisions.You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.This combination indicates that FMC Technologies is a potential outperformer and a solid choice for growth investors.Research Chief Names "Single Best Pick to Double"From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: FMC und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Quelle: Zacks

Nachrichten zu Fresenius Medical Care (FMC) St.

Analysen zu Fresenius Medical Care (FMC) St.

DatumRatingAnalyst
08.05.2026Fresenius Medical Care (FMC) St UnderperformJefferies & Company Inc.
08.05.2026Fresenius Medical Care (FMC) St KaufenDZ BANK
07.05.2026Fresenius Medical Care (FMC) St Equal WeightBarclays Capital
06.05.2026Fresenius Medical Care (FMC) St NeutralGoldman Sachs Group Inc.
06.05.2026Fresenius Medical Care (FMC) St HoldDeutsche Bank AG
DatumRatingAnalyst
08.05.2026Fresenius Medical Care (FMC) St KaufenDZ BANK
13.03.2026Fresenius Medical Care (FMC) St KaufenDZ BANK
03.12.2025Fresenius Medical Care (FMC) St BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
07.11.2025Fresenius Medical Care (FMC) St BuyGoldman Sachs Group Inc.
05.11.2025Fresenius Medical Care (FMC) St KaufenDZ BANK
DatumRatingAnalyst
07.05.2026Fresenius Medical Care (FMC) St Equal WeightBarclays Capital
06.05.2026Fresenius Medical Care (FMC) St NeutralGoldman Sachs Group Inc.
06.05.2026Fresenius Medical Care (FMC) St HoldDeutsche Bank AG
05.05.2026Fresenius Medical Care (FMC) St Equal WeightBarclays Capital
05.05.2026Fresenius Medical Care (FMC) St NeutralGoldman Sachs Group Inc.
DatumRatingAnalyst
08.05.2026Fresenius Medical Care (FMC) St UnderperformJefferies & Company Inc.
06.05.2026Fresenius Medical Care (FMC) St SellUBS AG
06.05.2026Fresenius Medical Care (FMC) St UnderweightJP Morgan Chase & Co.
05.05.2026Fresenius Medical Care (FMC) St UnderweightJP Morgan Chase & Co.
05.05.2026Fresenius Medical Care (FMC) St UnderperformJefferies & Company Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Fresenius Medical Care (FMC) St. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen